Skip to content

Clinical Observation of Jianpi Yishen Shengjing Formula in the Treatment of Spleen and Kidney Deficiency Syndrome in Oligoasthenospermia

Clinical Observation of Jianpi Yishen Shengjing Formula in the Treatment of Spleen and Kidney Deficiency Syndrome in Oligoasthenospermia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001180
Enrollment
Unknown
Registered
2025-06-15
Start date
2025-04-02
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligoasthenospermia

Interventions

Treatment group:Jianpi Yishen Shengjing Formula combined with Levocarnitine oral solution

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Wesitern Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Men who meet the Western medical diagnostic criteria for oligoasthenospermia; 2.Individuals who are diagnosed with spleen-kidney deficiency syndrome according to traditional Chinese medicine (TCM) standards for oligoasthenospermia; 3.Males aged between 20 and 45 years old with a desire for fertility; 4.Participants who have not taken medications that could affect the study outcomes within the three months prior to enrollment, such as finasteride, methotrexate, cyclophosphamide, cimetidine, etc.; 5.Individuals with normal sexual function, and no definitive etiology identified through a comprehensive baseline examination of relevant systemic indicators and a specialized examination of the urogenital system; 6.Those who understand and agree to participate in this study and have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Individuals with abnormal chromosomal tests or endocrine examinations; 2.Patients with azoospermia or organic lesions of the reproductive organs; 3.Those with abnormal diseases of the cardiovascular, hepatorenal systems, or hematopoietic functions; 4.Individuals with diseases that may affect semen quality, such as acute prostatitis, epididymal tuberculosis, cryptorchidism, varicocele, etc.; 5.People with allergic constitution or hypersensitivity to the medication, as well as those with impaired liver or kidney functions; 6.Patients with poor habits that significantly affect semen quality and those with psychiatric disorders (such as long-term alcohol consumption, smoking, staying up late, sauna bathing, etc.).

Design outcomes

Primary

MeasureTime frame
Percentage of Progressive Motile Sperm;

Secondary

MeasureTime frame
Percentage of Normal Morphology Sperm;Cumulative Pregnancy Rate;sex hormone levels;Total Motility Rate of Sperm;Total Sperm Count;Semen Volume;Sperm Concentration;Syndrome Score Scale of Traditional Chinese Medicine;

Countries

China

Contacts

Public ContactYu Peng

Yueyang Hospital of Integrated Traditional Chinese and Wesitern Medicine, Shanghai University of Traditional Chinese Medicine

drypeng@sina.com+86 18930568233

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026